NEA Management Company, LLC Q1 2020 Filing
Filed May 6, 2020
Portfolio Value
$1.9T
Holdings
50
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (50 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —RA PHARMACEUTICALS INC | 6,138,797 | $294.7B | 15.40% | |
| 2 | OYSTOYSTER POINT PHARMA INC | 5,925,287 | $207.4B | 10.84% | |
| 3 | SPTSPROUT SOCIAL INC | 9,046,080 | $144.4B | 7.54% | |
| 4 | ALLKGUSDALLAKOS INC | 2,268,188 | $100.9B | 5.27% | |
| 5 | NETCLOUDFLARE INC | 4,059,376 | $95.3B | 4.98% | |
| 6 | ARDXARDELYX INC | 16,135,047 | $91.7B | 4.79% | |
| 7 | CRSPCRISPR THERAPEUTICS AG | 2,090,678 | $88.7B | 4.63% | |
| 8 | BDTXBLACK DIAMOND THERAPEUTICS INC | 3,449,845 | $86.1B | 4.50% | |
| 9 | AUPHAURINIA PHARMACEUTICALS INC | 5,172,683 | $75.1B | 3.92% | |
| 10 | RYTMRHYTHM PHARMACEUTICALS INC | 4,912,306 | $74.8B | 3.91% | |
| 11 | —MERSANA THERAPEUTICS INC | 11,963,649 | $69.7B | 3.64% | |
| 12 | —EPIZYME INC | 4,377,518 | $67.9B | 3.55% | |
| 13 | —IMARA INC | 4,017,170 | $64.4B | 3.36% | |
| 14 | MIRMMIRUM PHARMACEUTICALS INC | 4,187,801 | $58.6B | 3.06% | |
| 15 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 17,082,611 | $46.5B | 2.43% | |
| 16 | GRTXGALERA THERAPEUTICS INC | 4,362,986 | $41.4B | 2.17% | |
| 17 | —CASPER SLEEP INC | 6,226,040 | $26.7B | 1.40% | |
| 18 | TREURTRILLIUM THERAPEUTICS INC | 5,736,363 | $23.2B | 1.21% | |
| 19 | —PHASEBIO PHARMACEUTICALS INC | 6,643,704 | $22.0B | 1.15% | |
| 20 | GLYCEURGLYCOMIMETICS INC | 9,089,041 | $20.7B | 1.08% | |
| 21 | SENS1GBPSENSEONICS HOLDINGS INC | 29,761,683 | $18.8B | 0.98% | |
| 22 | TRVITREVI THERAPEUTICS INC | 4,441,360 | $14.6B | 0.76% | |
| 23 | MEIPUSDMEI PHARMA INC | 8,533,072 | $13.7B | 0.72% | |
| 24 | CSBRCHAMPIONS ONCOLOGY INC | 1,713,720 | $12.7B | 0.66% | |
| 25 | GNCAQGENOCEA BIOSCIENCES INC | 7,225,676 | $12.4B | 0.65% | |
| 26 | LQDALIQUIDIA TECHNOLOGIES INC | 2,486,062 | $11.7B | 0.61% | |
| 27 | XENEXENON PHARMACEUTICALS INC | 992,107 | $11.3B | 0.59% | |
| 28 | —OBSEVA SA | 4,586,563 | $11.1B | 0.58% | |
| 29 | —AFFIMED NV | 6,126,488 | $9.7B | 0.51% | |
| 30 | TPIVDEURMARKER THERAPEUTICS INC | 5,000,000 | $9.5B | 0.50% | |
| 31 | —MILLENDO THERAPEUTICS INC | 1,766,779 | $9.3B | 0.49% | |
| 32 | 0HJQAVEO PHARMACEUTICALS INC | 2,524,387 | $9.1B | 0.48% | |
| 33 | —STRONGBRIDGE BIOPHARMA PLC | 4,141,308 | $7.8B | 0.41% | |
| 34 | —SYNLOGIC INC | 4,229,410 | $7.3B | 0.38% | |
| 35 | BEBLOOM ENERGY CORP | 1,333,333 | $7.0B | 0.36% | |
| 36 | CTIC1USDCTI BIOPHARMA CORP | 7,140,450 | $6.6B | 0.34% | |
| 37 | SURFUSDSURFACE ONCOLOGY INC | 3,315,149 | $6.2B | 0.32% | |
| 38 | RIGLUSDRIGEL PHARMACEUTICALS INC | 3,243,150 | $5.1B | 0.26% | |
| 39 | VRNAVERONA PHARMA PLC | 1,219,674 | $5.0B | 0.26% | |
| 40 | LXRXLEXICON PHARMACEUTICALS INC | 2,382,286 | $4.6B | 0.24% | |
| 41 | 4NX1LUMOS PHARMA INC | 526,663 | $4.5B | 0.23% | |
| 42 | —DASAN ZHONE SOLUTIONS INC | 956,255 | $4.0B | 0.21% | |
| 43 | ERYP1EURERYTECH PHARMA SA | 625,000 | $3.3B | 0.17% | |
| 44 | ASNSUSDX4 PHARMACEUTICALS INC | 333,333 | $3.3B | 0.17% | |
| 45 | —TREVENA INC | 3,811,691 | $2.2B | 0.11% | |
| 46 | —REGULUS THERAPEUTICS INC | 2,052,455 | $946.0M | 0.05% | |
| 47 | —AKARI THERAPEUTICS PLC | 452,167 | $656.0M | 0.03% | |
| 48 | TCONTRACON PHARMACEUTICALS INC | 346,718 | $589.0M | 0.03% | |
| 49 | —SUNESIS PHARMACEUTICALS INC | 1,298,274 | $539.0M | 0.03% | |
| 50 | —ENDOLOGIX INC | 249,022 | $172.0M | 0.01% |